Kim Kelly on Clinical Practice Guidelines for Mucositis

Kim Kelly, RN, OCN
Published: Wednesday, May 02, 2012

Kim Kelly, RN, OCN, Oncology, John Theurer Cancer Center, Hackensack University Medical Center, discusses the analysis that led to the new MASCC/ISOO clinical practice guidelines for managing mucositis, presented in an abstract at the 2012 ONS Annual Congress.

The goal of the research was to find evidence-based guidelines for preventing and treating mucositis. Medline data was used to examine groups of individuals with mucositis, the treatments used, and the efficacy of the treatment. The goal of the research was to create solid guidelines for the prevention, administration, and treatment of patients with mucositis.

The researchers looked for interventions that would help ease pain if mucositis already existed or that could help prevent the occurrence altogether.

The new guidelines support the use of several mouth rinses, including those containing doxepin, benzydamine, and morphine. Additionally, there is support for using transdermal fentanyl, palifermin, oral care protocols, cryotherapy, and patient-controlled analgesia with morphine. However, there was no evidence to recommend the use of several interventions, such as chlorhexidine.

<<< View more from the 2012 ONS Congress

Kim Kelly, RN, OCN, Oncology, John Theurer Cancer Center, Hackensack University Medical Center, discusses the analysis that led to the new MASCC/ISOO clinical practice guidelines for managing mucositis, presented in an abstract at the 2012 ONS Annual Congress.

The goal of the research was to find evidence-based guidelines for preventing and treating mucositis. Medline data was used to examine groups of individuals with mucositis, the treatments used, and the efficacy of the treatment. The goal of the research was to create solid guidelines for the prevention, administration, and treatment of patients with mucositis.

The researchers looked for interventions that would help ease pain if mucositis already existed or that could help prevent the occurrence altogether.

The new guidelines support the use of several mouth rinses, including those containing doxepin, benzydamine, and morphine. Additionally, there is support for using transdermal fentanyl, palifermin, oral care protocols, cryotherapy, and patient-controlled analgesia with morphine. However, there was no evidence to recommend the use of several interventions, such as chlorhexidine.

<<< View more from the 2012 ONS Congress


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Pediatric Hepatic Veno-Occlusive Disease: Integrating Novel Therapeutic Strategies to Overcome Post-Transplant ObstaclesMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x